Prevalence of pterygium and pinguecula and their risk factors: Tehran Geriatric Eye Study
Author:
Corresponding Author:

Hassan Hashemi. Noor Ophthalmology Research Center, Noor Eye Hospital, Tehran 1983963113, Iran. hhashemi@noorvision.com

Fund Project:

Supported by National Institute for Medical Research Development (NIMAD) affiliated with the Iranian Ministry of Health and Medical Education (No.963660).

  • Article
  • | |
  • Metrics
  • |
  • Reference [43]
  • |
  • Related [20]
  • | | |
  • Comments
    Abstract:

    AIM: To explore the prevalence of pterygium and pinguecula and their risk factors. METHODS: This population-based cross-sectional study was conducted on geriatric population aged 60 and over in Tehran, Iran from Jan 2019 to Jan 2020. Selected subjects were interviewed and subjected to optometric and ophthalmic examinations. RESULTS: The age and sex standardized prevalence of pterygium and pinguecula was 3.64% [95% confidence interval (CI): 2.94%–4.49%] and 55.57% (95%CI: 52.89%–58.22%), respectively. The prevalence of pterygium was 4.52% (95%CI: 3.5%–5.81%) in men and 2.79% (95%CI: 1.97%–3.94%) in women and the prevalence of pinguecula was 64.56% (95%CI: 60.92%–68.03%) in men and 46.72% (95%CI: 43.74%–49.72%) in women. According to the results of multiple logistic regression, pinguecula had a significant correlation with male sex [odds ratio (OR): 2.21, 95%CI: 1.63–2.99] and education level (OR: 0.52, 95%CI: 0.35-0.77) and pterygium had a significant relationship with male sex (OR: 2.2, 95%CI: 1.38–3.52), socioeconomic status (SES, OR: 0.5, 95%CI: 0.26–0.97), education level (OR: 0.22, 95%CI: 0.08–0.61). CONCLUSION: The prevalence of pinguecula and pterygium in this study are lower than other studies. Sex, SES, and education level are the risk factors of the prevalence of pinguecula and pterygium.

    Reference
    1 Rezvan F, Khabazkhoob M, Hooshmand E, et al. Prevalence and risk factors of pterygium: a systematic review and meta-analysis. Surv Ophthalmol 2018;63(5):719-735.
    2 Viveiros MMH, Silva MG, da Costa JGM, et al. Anti-inflammatory effects of α-humulene and β-caryophyllene on pterygium fibroblasts. Int J Ophthalmol 2022;15(12):1903-1907.
    3 Soliman W, Mohamed TA. Spectral domain anterior segment optical coherence tomography assessment of pterygium and pinguecula. Acta Ophthalmol 2012;90(5):461-465.
    4 Xu WW, Li X. The effect of pterygium on front and back corneal astigmatism and aberrations in natural-light and low-light conditions. BMC Ophthalmol 2024;24(1):7.
    5 Yoon CH, Seol BR, Choi HJ. Effect of pterygium on corneal astigmatism, irregularity and higher-order aberrations: a comparative study with normal fellow eyes. Sci Rep 2023;13:7328.
    6 McGlacken-Byrne AB, Drinkwater JJ, MacKey DA, et al. Gender and ethnic differences in pterygium prevalence: an audit of remote Australian clinics. Clin Exp Optom 2021;104(1):74-77.
    7 Hampel U, Wasielica-Poslednik J, Ries L, et al. Prevalence of pterygium and identification of associated factors in a German population - results from the Gutenberg Health Study. Acta Ophthalmol 2021;99(1):e130-e131.
    8 Fernandes AG, Berezovsky A, Watanabe SES, et al. Prevalence of ocular findings regardless of visual acuity status in older adults from the Brazilian Amazon Region. Sci Rep 2021;11(1):23710.
    9 Wang YH, Shan GL, Gan LY, et al. Prevalence and associated factors for pterygium in Han and Mongolian adults: a cross-sectional study in Inner Mongolian, China. BMC Ophthalmol 2020;20(1):45.
    10 Fernandes AG, Salomão SR, Ferraz NN, et al. Pterygium in adults from the Brazilian Amazon Region: prevalence, visual status and refractive errors. Br J Ophthalmol 2020;104(6):757-763.
    11 Le QH, Xiang J, Cui XH, et al. Prevalence and associated factors of pinguecula in a rural population in Shanghai, Eastern China. Ophthalmic Epidemiol 2015;22(2):130-138.
    12 Shah SI, Shah SA, Rai P. Factors associated with pterygium based on history and clinical examination of patients in Pakistan. J Curr Ophthalmol 2016;28(2):91-92.
    13 Zhang JF, Qin B, Liu BH, et al. Prevalence and associated factors for pterygium in a Chinese rural population with type 2 diabetes in a cross-sectional study: Jiangsu Diabetic Eye Disease Study (JDEDS). Int Ophthalmol 2023;43(2):411-422.
    14 Qadi R, AlAmri A, Elnashar M, et al. Prevalence of pterygium and associated risk factors in the high-altitude area of Ta’if City, Saudi Arabia. Cureus 2021;13(1):e12638.
    15 Fang XL, Chong CCY, Thakur S, et al. Ethnic differences in the incidence of pterygium in a multi-ethnic Asian population: the Singapore Epidemiology of Eye Diseases Study. Sci Rep 2021;11(1):501.
    16 Modenese A, Chou BR, Ádám B, et al. Occupational exposure to solar radiation and the eye: a call to implement health surveillance of outdoor workers. Med Lav 2023;114(4):e2023032.
    17 Wang M, Gan L, Cui J, et al. Prevalence and risk factors of refractive error in Qinghai, China: a cross-sectional study in Han and Tibetan adults in Xining and surrounding areas. BMC Ophthalmol 2021;21(1):260.
    18 Rezvan F, Hashemi H, Emamian MH, et al. The prevalence and determinants of pterygium and pinguecula in an urban population in Shahroud, Iran. Acta Med Iran 2012;50(10):689-696.
    19 Hashemi H, Khabazkhoob M, Yekta A, et al. The prevalence and determinants of pterygium in rural areas. J Curr Ophthalmol 2017;29(3):194-198.
    20 Tan DT, Chee SP, Dear KB, et al. Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision. Arch Ophthalmol 1997;115(10): 1235-1240.
    21 Cao XG, Li XX, Bao Y. Relationship between pterygium and age-related cataract among rural populations living in two different latitude areas in China. Int J Clin Exp Med 2017;10(2):3494-3501.
    22 Wang JW, Zhang Y, Chen XD, et al. Epidemiologic survey of pterygium in the middle-aged and the senile in defined rural area of Heilongjiang Province. Guoji Yanke Zazhi(Int Eye Sci) 2016;16(5):930-933.
    23 Anbesse DH, Kassa T, Kefyalew B, et al. Prevalence and associated factors of pterygium among adults living in Gondar city, Northwest Ethiopia. PLoS One 2017;12(3):e0174450.
    24 Shrestha P, Kaiti R. A hospital based study of pterygium in tertiary care hospital of Nepal. Kathmandu Univ Med J (KUMJ) 2016;14(55):192-197.
    25 Ke HQ, Dong YJ, Liu H, et al. Prevalence and risk factors for pterygium in six rural regions of Yunnan Province. Zhonghua Yan Ke Za Zhi 2022;58(10):769-777.
    26 Tesfai B, Kebede S, Kibreab F, et al. Prevalence of solar keratopathy, pterygium and cataract in the islands of northern red sea zone, Eritrea: cross-sectional study, 2021. Clin Ophthalmol 2021;15:2983-2991.
    27 Fekadu SA, Assem AS, Adimassu NF. Prevalence of pterygium and its associated factors among adults aged 18 years and above in Gambella town, Southwest Ethiopia, May 2019. PLoS One 2020;15(9):e0237891.
    28 Pan ZX, Shan GL, Wang XJ, et al. Prevalence and risk factors of pterygium in Han and Yugur populations in Gansu Province, China. Zhonghua Yan Ke Za Zhi 2020;56(8):600-607.
    29 Kassie Alemayehu T, Addis Y, Yenegeta Bizuneh Z, et al. Prevalence and associated factors of pterygium among adults living in kolla diba town, northwest Ethiopia. Clin Ophthalmol 2020;14:245-255.
    30 Bikbov MM, Zainullin RM, Kazakbaeva GM, et al. Pterygium prevalence and its associations in a Russian population: the Ural eye and medical study. Am J Ophthalmol 2019;205:27-34.
    31 Pan ZX, Cui JT, Shan GL, et al. Prevalence and risk factors for pterygium: a cross-sectional study in Han and Manchu ethnic populations in Hebei, China. BMJ Open 2019;9(2):e025725.
    32 Fotouhi A, Hashemi H, Khabazkhoob M, et al. Prevalence and risk factors of pterygium and pinguecula: the Tehran Eye Study. Eye (Lond) 2009;23(5):1125-1129.
    33 Wong TY, Foster PJ, Johnson GJ, et al. The prevalence and risk factors for pterygium in an adult Chinese population in Singapore: the Tanjong Pagar survey. Am J Ophthalmol 2001;131(2):176-183.
    34 Song PG, Chang XL, Wang ML, et al. Variations of pterygium prevalence by age, gender and geographic characteristics in China: a systematic review and meta-analysis. PLoS One 2017;12(3):e0174587.
    35 Gupta M, Arya S, Agrawal P, et al. Unravelling the molecular tapestry of pterygium: insights into genes for diagnostic and therapeutic innovations. Eye (Lond) 2024;38(15):2880-2887.
    36 Lu P, Chen XM, Kang Y, et al. Pterygium in tibetans: a population-based study in China. Clin Exp Ophthalmol 2007;35(9):828-833.
    37 Nemet AY, Vinker S, Segal O, et al. Epidemiology and associated morbidity of pterygium: a large, community-based case-control study. Semin Ophthalmol 2016;31(5):446-451.
    38 Lingham G, Kugelman J, Charng J, et al. Conjunctival ultraviolet autofluorescence area decreases with age and sunglasses use. Br J Ophthalmol 2023;107(5):614-620.
    39 Zhang XZ, Beckles GL, Chou CF, et al. Socioeconomic disparity in use of eye care services among US adults with age-related eye diseases: National Health Interview Survey, 2002 and 2008. JAMA Ophthalmol 2013;131(9):1198-1206.
    40 Luthra R, Nemesure BB, Wu SY, et al. Frequency and risk factors for pterygium in the Barbados eye study. Arch Ophthalmol 2001;119(12):1827-1832.
    41 Khanna RC, Marmamula S, Cicinelli MV, et al. Fifteen-year incidence rate and risk factors of pterygium in the Southern Indian state of Andhra Pradesh. Br J Ophthalmol 2021;105(5):619-624.
    42 Lu J, Wang Z, Lu P, et al. Pterygium in an aged Mongolian population: a population-based study in China. Eye (Lond) 2009;23(2):421-427.
    43 Viso E, Gude F, Rodríguez-Ares MT. Prevalence of pinguecula and pterygium in a general population in Spain. Eye (Lond) 2011;25(3):350-357.
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

Alireza Hashemi, Mohamadreza Aghamirsalim, Hassan Hashemi,/et al.Prevalence of pterygium and pinguecula and their risk factors: Tehran Geriatric Eye Study. Int J Ophthalmol, 2025,18(4):699-706

Copy
Share
Article Metrics
  • Abstract:13
  • PDF: 18
  • HTML: 0
  • Cited by: 0
Publication History
  • Received:May 15,2024
  • Revised:August 20,2024
  • Online: March 20,2025